Valeritas Holdings Current Ratio 2015-2019 | VLRX

Valeritas Holdings current ratio from 2015 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Valeritas Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.05B $0.02B 3.32
2018-12-31 $0.06B $0.01B 4.47
2018-09-30 $0.04B $0.01B 3.00
2018-06-30 $0.05B $0.01B 4.04
2018-03-31 $0.03B $0.01B 2.56
2017-12-31 $0.04B $0.01B 3.02
2017-09-30 $0.05B $0.01B 3.88
2017-06-30 $0.06B $0.01B 4.63
2017-03-31 $0.07B $0.01B 5.39
2016-12-31 $0.02B $0.01B 2.06
2016-09-30 $0.03B $0.01B 2.66
2016-06-30 $0.04B $0.01B 3.21
2016-03-31 $0.00B $0.00B 0.00
2015-12-31 $0.02B $0.08B 0.22
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.00B $0.00B 0.20
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.015B $0.026B
Valeritas Holdings Inc. is a commercial-stage medical technology company which focused on developing technologies for Type 2 diabetes. The company's product pipeline consists of V-Go (R) Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for Type 2 diabetes which enables patients to administer a continuous preset basal rate infusion of insulin. Valeritas Holdings Inc. is headquartered in Bridgewater, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.444B 29.01
Medtronic (MDT) Ireland $132.989B 19.00
Stryker (SYK) United States $76.293B 27.23
Boston Scientific (BSX) United States $58.421B 28.01
Baxter (BAX) United States $41.972B 26.45
Zimmer Biomet Holdings (ZBH) United States $24.047B 15.45
Smith & Nephew SNATS (SNN) United Kingdom $19.169B 0.00
ResMed (RMD) United States $17.375B 33.20
Canopy Growth (CGC) Canada $13.976B 0.00
Bio-Rad Laboratories (BIO) United States $8.970B 47.55
Aurora Cannabis (ACB) Canada $7.616B 75.10
Insulet (PODD) United States $7.025B 511.83
Hill-Rom Holdings (HRC) United States $6.932B 21.01
Perrigo (PRGO) Ireland $6.005B 10.15
Haemonetics (HAE) United States $5.941B 48.49
GW Pharmaceuticals (GWPH) United Kingdom $5.196B 0.00
ICU Medical (ICUI) United States $5.076B 30.28
Hutchison China MediTech (HCM) China $3.869B 0.00
Neogen (NEOG) United States $3.133B 50.95
NuVasive (NUVA) United States $2.997B 24.48
Agios Pharmaceuticals (AGIO) United States $2.860B 0.00
National Vision Holdings (EYE) United States $2.450B 52.20
Quidel (QDEL) United States $2.347B 24.36
Aphria (APHA) $1.783B 0.00
Cardiovascular Systems (CSII) United States $1.472B 845.60
HEXO (HEXO) $1.376B 0.00
Phibro Animal Health (PAHC) United States $1.239B 18.57
AtriCure (ATRC) United States $1.167B 0.00
VAREX IMAGING (VREX) United States $1.115B 23.67
Lantheus Holdings (LNTH) United States $1.072B 28.46
OrganiGram Holdings (OGI) Canada $0.985B 0.00
NanoString Technologies (NSTG) United States $0.910B 0.00
PetIQ (PETQ) United States $0.865B 21.00
Quanterix (QTRX) United States $0.842B 0.00
Omeros (OMER) United States $0.804B 0.00
MacroGenics (MGNX) United States $0.792B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.743B 20.83
Cerus (CERS) United States $0.663B 0.00
TG Therapeutics (TGTX) United States $0.610B 0.00
Surmodics (SRDX) United States $0.552B 80.18
LeMaitre Vascular (LMAT) United States $0.544B 26.35
OraSure Technologies (OSUR) United States $0.538B 24.77
Meridian Bioscience (VIVO) United States $0.486B 14.84
Zynex (ZYXI) United States $0.378B 39.10
Evolus (EOLS) United States $0.374B 0.00
Vapotherm (VAPO) United States $0.372B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.361B 0.00
Utah Medical Products (UTMD) United States $0.320B 22.16
BioLife Solutions (BLFS) United States $0.308B 96.24
Bovie Medical (APYX) United States $0.211B 0.00
Cytosorbents (CTSO) United States $0.209B 0.00
Owens & Minor (OMI) United States $0.184B 3.91
Chimerix (CMRX) United States $0.174B 0.00
Rockwell Medical (RMTI) United States $0.170B 0.00
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
BRAINSWAY LTD (BWAY) Israel $0.114B 0.00
Neurotrope (NTRP) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.102B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
United-Guardian (UG) United States $0.084B 18.55
Surface Oncology (SURF) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Trinity Biotech (TRIB) Ireland $0.041B 14.17
Senestech (SNES) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.031B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Myomo (MYO) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.85